Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Medical Aesthetic Products Market

ID: MRFR/MED/41750-CR
128 Pages
Rahul Gotadki
Last Updated: March 31, 2026

Medical Aesthetic Products Market Research Report Information by Product (Botulinum Toxin (Botox), Dermal Fillers), by Application (Hair Removal, Skin Resurfacing, Facial Rejuvenation, Liposuction, Facelifts, Skin Grafting, Wrinkle Reduction, Others), by Gender (Male, Female), by End User (Hospitals & Dermatological Clinics, Medical Spas, Beauty Clinics), by Region (North America, Europe, Asia-Pacific, Rest of the World)–Market Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Medical Aesthetic Products Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Product (USD Million) | |
      1. 4.1.1 Botulinum toxin (Botox) | |
      2. 4.1.2 Dermal fillers |
    2. 4.2 Healthcare, BY Application (USD Million) | |
      1. 4.2.1 Hair removal | |
      2. 4.2.2 Skin resurfacing | |
      3. 4.2.3 Facial rejuvenation | |
      4. 4.2.4 Liposuction | |
      5. 4.2.5 Facelifts | |
      6. 4.2.6 Skin grafting | |
      7. 4.2.7 Wrinkle reduction | |
      8. 4.2.8 Others |
    3. 4.3 Healthcare, BY Gender (USD Million) | |
      1. 4.3.1 Male | |
      2. 4.3.2 Female |
    4. 4.4 Healthcare, BY End User (USD Million) | |
      1. 4.4.1 Hospitals & Dermatological Clinics | |
      2. 4.4.2 Medical Spas | |
      3. 4.4.3 Beauty Clinics |
    5. 4.5 Healthcare, BY Region (USD Million) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Allergan (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Galderma (CH) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Revance Therapeutics (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Medytox (KR) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Hugel (KR) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Ipsen (FR) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Medytox (KR) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Sientra (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Hugel (KR) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY PRODUCT |
    7. 6.4 US MARKET ANALYSIS BY APPLICATION |
    8. 6.5 US MARKET ANALYSIS BY GENDER |
    9. 6.6 US MARKET ANALYSIS BY END USER |
    10. 6.7 CANADA MARKET ANALYSIS BY PRODUCT |
    11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
    12. 6.9 CANADA MARKET ANALYSIS BY GENDER |
    13. 6.10 CANADA MARKET ANALYSIS BY END USER |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY PRODUCT |
    16. 6.13 GERMANY MARKET ANALYSIS BY APPLICATION |
    17. 6.14 GERMANY MARKET ANALYSIS BY GENDER |
    18. 6.15 GERMANY MARKET ANALYSIS BY END USER |
    19. 6.16 UK MARKET ANALYSIS BY PRODUCT |
    20. 6.17 UK MARKET ANALYSIS BY APPLICATION |
    21. 6.18 UK MARKET ANALYSIS BY GENDER |
    22. 6.19 UK MARKET ANALYSIS BY END USER |
    23. 6.20 FRANCE MARKET ANALYSIS BY PRODUCT |
    24. 6.21 FRANCE MARKET ANALYSIS BY APPLICATION |
    25. 6.22 FRANCE MARKET ANALYSIS BY GENDER |
    26. 6.23 FRANCE MARKET ANALYSIS BY END USER |
    27. 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT |
    28. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATION |
    29. 6.26 RUSSIA MARKET ANALYSIS BY GENDER |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END USER |
    31. 6.28 ITALY MARKET ANALYSIS BY PRODUCT |
    32. 6.29 ITALY MARKET ANALYSIS BY APPLICATION |
    33. 6.30 ITALY MARKET ANALYSIS BY GENDER |
    34. 6.31 ITALY MARKET ANALYSIS BY END USER |
    35. 6.32 SPAIN MARKET ANALYSIS BY PRODUCT |
    36. 6.33 SPAIN MARKET ANALYSIS BY APPLICATION |
    37. 6.34 SPAIN MARKET ANALYSIS BY GENDER |
    38. 6.35 SPAIN MARKET ANALYSIS BY END USER |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY GENDER |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY PRODUCT |
    45. 6.42 CHINA MARKET ANALYSIS BY APPLICATION |
    46. 6.43 CHINA MARKET ANALYSIS BY GENDER |
    47. 6.44 CHINA MARKET ANALYSIS BY END USER |
    48. 6.45 INDIA MARKET ANALYSIS BY PRODUCT |
    49. 6.46 INDIA MARKET ANALYSIS BY APPLICATION |
    50. 6.47 INDIA MARKET ANALYSIS BY GENDER |
    51. 6.48 INDIA MARKET ANALYSIS BY END USER |
    52. 6.49 JAPAN MARKET ANALYSIS BY PRODUCT |
    53. 6.50 JAPAN MARKET ANALYSIS BY APPLICATION |
    54. 6.51 JAPAN MARKET ANALYSIS BY GENDER |
    55. 6.52 JAPAN MARKET ANALYSIS BY END USER |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY GENDER |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY GENDER |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END USER |
    64. 6.61 THAILAND MARKET ANALYSIS BY PRODUCT |
    65. 6.62 THAILAND MARKET ANALYSIS BY APPLICATION |
    66. 6.63 THAILAND MARKET ANALYSIS BY GENDER |
    67. 6.64 THAILAND MARKET ANALYSIS BY END USER |
    68. 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT |
    69. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATION |
    70. 6.67 INDONESIA MARKET ANALYSIS BY GENDER |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END USER |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY GENDER |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END USER |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT |
    78. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATION |
    79. 6.76 BRAZIL MARKET ANALYSIS BY GENDER |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END USER |
    81. 6.78 MEXICO MARKET ANALYSIS BY PRODUCT |
    82. 6.79 MEXICO MARKET ANALYSIS BY APPLICATION |
    83. 6.80 MEXICO MARKET ANALYSIS BY GENDER |
    84. 6.81 MEXICO MARKET ANALYSIS BY END USER |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY GENDER |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END USER |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENDER |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY GENDER |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY GENDER |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY GENDER |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END USER |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY PRODUCT, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Million) |
    114. 6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
    116. 6.113 HEALTHCARE, BY GENDER, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY GENDER, 2024 TO 2035 (USD Million) |
    118. 6.115 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.2.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.2.4 BY END USER, 2025-2035 (USD Million) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.3.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.3.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.3.4 BY END USER, 2025-2035 (USD Million) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.4.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.4.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.4.4 BY END USER, 2025-2035 (USD Million) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.5.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.5.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.5.4 BY END USER, 2025-2035 (USD Million) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.6.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.6.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.6.4 BY END USER, 2025-2035 (USD Million) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.7.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.7.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.7.4 BY END USER, 2025-2035 (USD Million) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.8.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.8.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.8.4 BY END USER, 2025-2035 (USD Million) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.9.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.9.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.9.4 BY END USER, 2025-2035 (USD Million) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.10.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.10.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.10.4 BY END USER, 2025-2035 (USD Million) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.11.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.11.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.11.4 BY END USER, 2025-2035 (USD Million) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.12.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.12.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.12.4 BY END USER, 2025-2035 (USD Million) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.13.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.13.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.13.4 BY END USER, 2025-2035 (USD Million) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.14.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.14.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.14.4 BY END USER, 2025-2035 (USD Million) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.15.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.15.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.15.4 BY END USER, 2025-2035 (USD Million) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.16.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.16.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.16.4 BY END USER, 2025-2035 (USD Million) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.17.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.17.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.17.4 BY END USER, 2025-2035 (USD Million) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.18.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.18.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.18.4 BY END USER, 2025-2035 (USD Million) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.19.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.19.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.19.4 BY END USER, 2025-2035 (USD Million) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.20.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.20.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.20.4 BY END USER, 2025-2035 (USD Million) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.21.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.21.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.21.4 BY END USER, 2025-2035 (USD Million) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.22.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.22.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.22.4 BY END USER, 2025-2035 (USD Million) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.23.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.23.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.23.4 BY END USER, 2025-2035 (USD Million) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.24.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.24.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.24.4 BY END USER, 2025-2035 (USD Million) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.25.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.25.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.25.4 BY END USER, 2025-2035 (USD Million) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.26.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.26.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.26.4 BY END USER, 2025-2035 (USD Million) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.27.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.27.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.27.4 BY END USER, 2025-2035 (USD Million) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.28.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.28.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.28.4 BY END USER, 2025-2035 (USD Million) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.29.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.29.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.29.4 BY END USER, 2025-2035 (USD Million) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.30.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.30.3 BY GENDER, 2025-2035 (USD Million) | |
      4. 7.30.4 BY END USER, 2025-2035 (USD Million) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Product (USD Million, 2025-2035)

  • Botulinum toxin (Botox)
  • Dermal fillers

Healthcare By Application (USD Million, 2025-2035)

  • Hair removal
  • Skin resurfacing
  • Facial rejuvenation
  • Liposuction
  • Facelifts
  • Skin grafting
  • Wrinkle reduction
  • Others

Healthcare By Gender (USD Million, 2025-2035)

  • Male
  • Female

Healthcare By End User (USD Million, 2025-2035)

  • Hospitals & Dermatological Clinics
  • Medical Spas
  • Beauty Clinics

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions